1591 |
Investigation of polymorphisms in human arylamine N-acetyltransferaseHickman, Dean January 1993 (has links)
No description available.
|
1592 |
Studies on human N-acetyltransferaseCoroneos, Erifili January 1992 (has links)
No description available.
|
1593 |
The preparation and properties of some bladder smooth muscle relaxantsSummers, Martin J. January 1996 (has links)
No description available.
|
1594 |
Studies on bacterial proline 4-hydroxylaseLawrence, Christopher C. January 1993 (has links)
No description available.
|
1595 |
An investigation into the long-term effects of experimental limbic epilepsy of exploratory behaviour of ratsNicholls, Briony Rachel January 1994 (has links)
No description available.
|
1596 |
Neural control of the urethra and the mechanisms underlying inhibitory transmission in smooth muscleBridgewater, Melissa January 1994 (has links)
No description available.
|
1597 |
Studies towards the total synthesis of aerocyanidinChen, Deqi January 1994 (has links)
No description available.
|
1598 |
Flow injection determination of drugs by enzyme inhibitionGhous, T. January 1995 (has links)
No description available.
|
1599 |
The pharmacology of nicotinic acetylcholine receptors in Heliothis virescens and Locusta migratoria neurones in vitroJackson, Charles E. P. January 1998 (has links)
No description available.
|
1600 |
Molecular pharmocology of cannabinoids and the novel cannabinoid receptor GPR55 in boneWhyte, Lauren Sarah January 2009 (has links)
Given the recent finding that the cannabinoid receptors CB<sub>1</sub> and CB<sub>2</sub> affect bone metabolism, we examined the role of GPR55 in bone biology. GPR55 was expressed in human and mouse osteoclasts and osteoblasts; expression was higher in human osteoclasts than in macrophage progenitors. Although the GPR55 agonists O-1602 and LPI inhibited mouse osteoclast formation <i>in vitro</i>, these ligands stimulated mouse and human osteoclast polarisation and resorption <i>in vitro</i> and caused activation of Rho and ERK1/2. These stimulatory effects on osteoclast function were attenuated in osteoclasts generated from GPR55<sup>-/-</sup> macrophages and by the GPR55 antagonist cannabidiol (CBD). Furthermore, treatment of mice with this non-psychoactive constituent of cannabis significantly reduced bone resorption <i>in vivo</i>. Consistent with the ability of GPR55 to suppress osteoclast formation but stimulate osteoclast function, histomorphometric and microcomputed tomographic analysis of the long bones from male GPR55<sup>-/-</sup> mice revealed increased numbers of morphologically-inactive osteoblasts, but a significant increase in the volume and thickness of trabecular bone and the presence of unresorbed cartilage. These data reveal a hitherto unrecognised role of GPR55 in bone physiology by regulating osteoclast number and function. In addition, this study also brings to light a newly identified effect of both the endogenous ligand, LPI , on osteoclasts and of the cannabis constituent, CBD, on osteoclasts and bone turnover <i>in vivo</i>. These results suggest that blocking GPR55 with small molecules similar to CBD may be beneficial in bone diseases associated with increased osteoclast activity such as osteoporosis.
|
Page generated in 0.023 seconds